JPMorgan analyst Chris Schott says Eli Lilly’s Q4 miss represents a buying opportunity as the company is positioned for strong growth in 2025. The company’s 2025 sales guidanc ...

Liontrust’s assets under management dropped by 5.3% to £24.6bn at the end of December 2024 following “concentrated” outflows.

Alongside the company’s results, Liontrust announced that its Sustainable Investment team’s suite of 10 UK-domiciled funds, ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...

Marshall Witt; Chief Financial Officer; TD Synnex Corp Ruplu Bhattacharya; Analyst; BofA Securities, Inc. Ashish Sabadra; Analyst; RBC Capital Markets George Wang; Analyst; Barclays Investment Bank ...

Q4 2024 Earnings Call Transcript January 10, 2025 TD SYNNEX Corporation misses on earnings expectations. Reported EPS is $2.3 ...

London-based Liontrust Asset Management has said it plans to cut more jobs after revealing net outflows of £1.6bn for the ...

Investment analysts at Telsey Advisory Group dropped their Q3 2026 EPS estimates for Nordstrom in a report released on Monday ...

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the ...

iQSTEL has been building a strong business platform with its customers, and by leveraging this trust, the company is now ...

TreeHouse, a huge supplier of private label food and beverages, also reaffirmed its FY24 guidance, including the expectation of sequential improvement in volume growth and profit margin in Q4. THS ...